Bellevue Life Sciences Acquisition Corp. (BLAC)
USD 11.32
(0.0%)
USD 11.32
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -818.76 Thousand | -4235.00 | -461.00 | -23.81 Thousand |
| Net Income | 403.78 Thousand | -35.38 Thousand | -3308.00 | -23.81 Thousand |
| Depreciation & Amortization | - | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 1.55 Million | 31.15 Thousand | 2847.00 | - |
| Other non-cash items | -2.77 Million | - | - | - |
| Investing Cash Flow | -33.82 Million | - | - | - |
| Investments in PPE | -4.00 | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | -70.38 Million | - | - | - |
| Sales/Maturities of investments | 36.55 Million | - | - | - |
| Other Investing Activities | -33.82 Million | - | - | - |
| Financing Cash Flow | 34.53 Million | 123.97 Thousand | -57.43 Thousand | 86.46 Thousand |
| Debt repayment | -1.14 Million | -800 Thousand | -110 Thousand | -300 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | -35.99 Million | - | - | - |
| Common Stock Issuance | 71.68 Million | -683.02 Thousand | -167.43 Thousand | -213.53 Thousand |
| Other Financing Activities | -1.39 Million | 1.6 Million | 220 Thousand | 600 Thousand |
| Accounts receivables | - | - | - | - |
| Accounts payables | 1.03 Million | 31.15 Thousand | - | - |
| Inventory | - | - | - | - |
| Other working capital | 1.55 Million | 31.15 Thousand | 2847.00 | - |
| Cash at beginning of period | 124.5 Thousand | 4757.00 | 62.65 Thousand | - |
| Cash at end of period | 15.41 Thousand | 124.5 Thousand | 4757.00 | 62.65 Thousand |
| Capital Expenditure | -4.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -109.08 Thousand | 119.74 Thousand | -57.89 Thousand | 62.65 Thousand |
| Free Cash Flow | -818.77 Thousand | -4235.00 | -461.00 | -23.81 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -97.29 Thousand | -60.43 Thousand | 403.78 Thousand | -86.17 Thousand | 78.18 Thousand | 301.46 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -853.57 Thousand | 499.47 Thousand | 1.55 Million | 735.44 Thousand | 397.09 Thousand | 161.21 Thousand |
| Other non-cash items | -465.5 Thousand | -480.82 Thousand | -2.77 Million | -928.76 Thousand | -618.49 Thousand | -810.3 Thousand |
| Investing Cash Flow | 17.2 Million | -120 Thousand | -33.82 Million | 36.37 Million | - | - |
| Investments in PPE | -2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -160 Thousand | -120 Thousand | -70.38 Million | -180 Thousand | - | - |
| Sales/Maturities of investments | 17.36 Million | - | 36.55 Million | 36.55 Million | - | - |
| Other Investing Activities | 17.2 Million | -120 Thousand | -33.82 Million | 36.37 Million | - | - |
| Financing Cash Flow | -15.67 Million | 150 Thousand | 34.53 Million | -36.14 Million | 200 Thousand | - |
| Debt repayment | -1.36 Million | -135 Thousand | -1.14 Million | -145 Thousand | -200 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -17.04 Million | - | -35.99 Million | -35.99 Million | - | - |
| Common Stock Issuance | - | - | 71.68 Million | -63.97 Million | - | - |
| Other Financing Activities | 10 Thousand | 15 Thousand | -1.39 Million | 55 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -495.7 Thousand | 466.33 Thousand | 1.03 Million | 581.39 Thousand | 233.86 Thousand | -119.94 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -853.57 Thousand | 499.47 Thousand | 1.55 Million | 735.44 Thousand | 163.22 Thousand | 161.21 Thousand |
| Cash at beginning of period | 3637.00 | 15.41 Thousand | 124.5 Thousand | 57.95 Thousand | 1181.00 | 348.8 Thousand |
| Cash at end of period | 119.11 Thousand | 3637.00 | 15.41 Thousand | 15.41 Thousand | 57.95 Thousand | 1181.00 |
| Capital Expenditure | -2.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 115.47 Thousand | -11.78 Thousand | -109.08 Thousand | -42.53 Thousand | 56.77 Thousand | -347.62 Thousand |
| Free Cash Flow | -1.41 Million | -41.78 Thousand | -818.76 Thousand | -279.49 Thousand | -143.22 Thousand | -347.62 Thousand |
BLYQ
IROHU
NWLXF
WOA
SAGARDEEP
6378